loading...

King's Parkinson's Disease Pain Scale (KPPS)

Chaudhuri KR; Trenkwalder C; Martinez-Martin P

Distributed by Mapi Research Trust

ProQolid

Distributed by Mapi Research Trust

Basic description

Published in 2015

WEBINAR:  An Author Webinar on the King's Parkinson's Disease Pain Scale - Recorded session available here!

Please note that a self-administered version has been developed and validated. The paper was presented in Berlin MDS and is due to be submitted for publication.

Authors

Chaudhuri KR; Trenkwalder C; Martinez-Martin P

Copyright
KPPS © K Ray-Chaudhuri, C Trenkwalder, P Martinez-Martin, 2012. All Rights Reserved
Objective
To evaluate the burden ( global and bedside) and characterize various phenotypes of pain in Parkinson Disease (PD) patients.
Therapeutic area
  • Nervous System Diseases
Therapeutic indication

Parkinson Disease

Type of Clinical Outcome Assessment (COA)
  • clinro ClinRO
Original language(s)
  • English for the UK
Bibliographic reference(s) of the original questionnaire

Chaudhuri KR, Rizos A, Trenkwalder C, Rascol O, Pal S, Martino D, Carroll C, Paviour D, Falup-Pecurariu C, Kessel B, Silverdale M, Todorova A, Sauerbier A, Odin P, Antonini A, Martinez-Martin P; EUROPAR and the IPMDS Non Motor PD Study Group. King's Parkinson's disease pain scale, the first scale for pain in PD: An  international validation. Mov Disord. 2015 Oct;30(12):1623-31. (PubMed Abstract)


Contact and conditions of use

Authors

Chaudhuri KR; Trenkwalder C; Martinez-Martin P

Professor K Ray Chaudhuri
Neurology, 9th Floor Ruskin Wing, 
Kings College Hospital, Denmark Hill,London SE5 9RS
UK
Tel: +44 (0) 20 7848 5681
E-mail: chaudhuriray@hotmail.com;ray.chaudhuri@kcl.ac.uk

Ray Chaudhuri publications (PubMed)

 

Dr. Claudia Trenkwalder
University of Goettingen and Paracelsus-Elena Hospital
Center of Parkinsonism and Movement Disorders, Klinikstr. 16
34128 Kassel
Germany
E-mail: ctrenkwalder@gmx.de

Claudia Trenkwalder publications (PubMed)

Contact information

Mapi Research Trust
PROVIDE™
27 rue de la Villette
69003 Lyon
France
Phone: +33 (0)4 72 13 66 66

Conditions of use

Non-Commercial Users

If you do not receive specific funding for your study, you may download the questionnaire directly:

  1. Log in or Register for free
  2. Click the 'Online distribution' tab in the left menu bar and follow the instructions

Tutorials are available on our FAQs.

Commercial Users

All requests have to be submitted through our online request management:

  1. Log in or Register for free
  2. Submit your request (Tutorials are available on our FAQs)
  3. In order to accelerate the process, you may attach the User Agreement (even if not finalized) to your online request. Click the link below for the user agreement template.
  4. Our PROVIDE team will get back to you with the needed information in a timely manner

Access fees

ROYALTY FEES* Commercial users Cost per study Between 3 675 € and 26 250 € (depending on the number of patients included in the study)
Cost per language Free
Funded academic research Cost per study Free
Cost per language Free
Not funded academic users Cost per study Free
Cost per language Free
DISTRIBUTION FEES* Commercial users Cost per study 1 000 €
Cost per language 500 €
Funded academic research Cost per study 300 €
Cost per language 50 €
Not funded academic users Cost per study Free
Cost per language Free

* Excluding VAT
Commercial users: Industry, CRO, any for-profit companies
Funded Academic research: Projects receiving funding from commerce, government, EU or registered charity. Funded academic research– sponsored by industry fits the “commercial users” category.
Not funded academic users, individual medical practice: Projects are not explicitly funded, but funding comes from overall departmental funds or from the University or individual funds

Conditions to translate

Please refer to the "Languages" tab

Conditions to implement in electronic applications

Exclusive licensor for e-versions of the KPPSMapi Research Trust

Academic and Commercial Users
  • Shall follow the “Conditions of use”  mentioned above
  • In addition, in case the electronic version of the KPPS is developed by a third party (IT Company, e-PRO vendor…), User shall check with Mapi Research Trust that this third party has signed the necessary License Agreement with Mapi Research Trust before developing the electronic version of the Questionnaire.

Information Technology (IT) Companies (incl. ePRO vendors)
  • In case of a one-shot development and commercial use of an electronic version of the KPPS by the IT Company, the IT Company shall:
    • Sign a “Specific-Study License Agreement with IT Company” with Mapi Research Trust
      • authorizing the electronic implementation of the KPPS for the specific study only
      • shall not permit the IT Company to promote the electronic version of the KPPS or its use for another study or another client
    • Pay a one-shot license fee per study to Mapi Research Trust: 500 Euros
  • In case of an IT Company who wishes to develop an electronic version of the KPPS and would like to obtain a non-exclusive license to market and promote their devices / tablets / smartphones / e-applications using the KPPS, the IT Company shall:
    • Sign a “General License Agreement with IT Company” with Mapi Research Trust
      • authorizing the electronic implementation of the KPPS on multiple devices for multiple studies and clients
      • permitting the IT Company to promote the electronic versions of the KPPS by any marketing means (including, but not limited to, IT Company’s  promotional documents / websites / press release / communication during conferences / webinars)
    • Pay an annual administrative fee of 2,500 Euros to Mapi Research Trust
    • Pay an annual royalty fee of 2,500 Euros to the authors

Review copy

Examination copies can only be used for the limited purpose of examining the suitability of the Questionnaire for subsequent research and/or clinical use, and cannot be used in research or in clinical practice or distributed to others.
You are not authorized to modify, retype, translate, copy or otherwise duplicate the Questionnaire except with the further and prior written permission of Mapi Research Trust / the developers / copyright holders / distributors.

Languages

Original language(s)

  • English for the UK

Translations

The listed translations may not have undergone a full linguistic validation process and may require further work to be suitable for use in a study. This list is subject to constant changes, therefore please check the status of translations with Mapi Research Trust / the developers / copyright holders / distributors.

KPPS

English for Australia
Finnish for Finland*
French for Canada
French for France*
German for Austria
German for Germany
Greek for Greece*
Hungarian for Hungary*
Italian for Italy
Japanese for Japan*
Korean for Korea*
Slovak for Slovakia*
Spanish for Spain
Spanish for the USA*
Swedish for Finland*
Swedish for Sweden
Turkish for Turkey
* Performed by Mapi

The author has selected Mapi as exclusive linguistic validation company to ensure the production of harmonized and consistent language versions.

For additional information on available translations of this instrument, or for a project involving new languages, please submit a request (tutorials available on our FAQs).

Conditions to translate

Commercial Users

Exclusive vendor for translation work for commercial users: Mapi

Academic Translation

If you wish to translate the questionnaire:

  1. Log in or Register for free
  2. Submit your request for translation online (Tutorials are available on our FAQs)
  3. Our PROVIDE team will send you a translation agreement along with Linguistic Validation Guidelines.

More information on translations

Online distribution

My study is not funded

  • I am a non-commercial user
  • I do not receive specific funding for my study
  • I intend to use the questionnaire in individual clinical practice or research study
Login SIGN up free

My study is funded

If your study is funded, or if you haven't found your translation in the Languages menu, please submit your request online.

Our team will get back to you as soon as possible.

E-versions

Conditions to implement in electronic applications

Please refer to the "Contact and conditions of use" tab

Member Access

Subscribe to PROQOLID to access to full informations

And get access to advanced descriptions of Clinical Outcome Assessments (COAs)!

A question? Contact us